{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:57:39Z","timestamp":1778914659548,"version":"3.51.4"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/nrneurol.2013.253","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T07:40:19Z","timestamp":1386661219000},"page":"12-13","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the natural history of Huntington disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Roger A.","family":"Barker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"BFnrneurol2013253_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1517\/14728210902918299","volume":"14","author":"SL Mason","year":"2009","unstructured":"Mason, S. L. & Barker, R. A. Emerging drug therapies in Huntington's disease. Expert Opin. Emerg. Drugs 14, 273\u2013297 (2009).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"BFnrneurol2013253_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi, S. J.  et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 10, 31\u201342 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2013253_CR3","doi-asserted-by":"publisher","unstructured":"Dorsey, E. R.  et al. Natural history of Huntington disease. JAMA Neurol. \n                    http:\/\/dx.doi.org\/10.1001\/jamaneurol.2013.4408\n                    \n                  .","DOI":"10.1001\/jamaneurol.2013.4408"},{"key":"BFnrneurol2013253_CR4","doi-asserted-by":"publisher","first-page":"e29522","DOI":"10.1371\/journal.pone.0029522","volume":"7","author":"E Dorsey","year":"2012","unstructured":"Huntington Study Group COHORT Investigators & Dorsey, E. Characterization of a large group of individuals with Huntington disease and their relatives enrolled in the COHORT study. PLoS ONE 7, e29522 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2013253_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi, S. J.  et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lan cet Neurol. 12, 637\u2013649 (2013).","journal-title":"Lan cet Neurol."},{"key":"BFnrneurol2013253_CR6","doi-asserted-by":"publisher","first-page":"RRN1260","DOI":"10.1371\/currents.RRN1260","volume":"3","author":"JM Burgunder","year":"2011","unstructured":"Burgunder, J. M.  et al. An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington's disease. PLoS Curr. 3, RRN1260 (2011).","journal-title":"PLoS Curr."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.253","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:11:48Z","timestamp":1684469508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2013.253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFnrneurol2013253"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2013.253","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}